PROTO, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 235
EU - Europa 193
AS - Asia 64
Totale 492
Nazione #
US - Stati Uniti d'America 235
SE - Svezia 63
IE - Irlanda 60
CN - Cina 40
SG - Singapore 21
FR - Francia 15
IT - Italia 13
FI - Finlandia 11
AT - Austria 8
UA - Ucraina 7
DE - Germania 6
GB - Regno Unito 5
BE - Belgio 3
IN - India 3
CZ - Repubblica Ceca 1
PL - Polonia 1
Totale 492
Città #
Dublin 59
Chandler 57
Nyköping 24
Beijing 19
Jacksonville 19
Ann Arbor 18
Singapore 17
Dearborn 10
New York 10
Ashburn 8
Cambridge 8
Princeton 8
Vienna 8
Boardman 7
Medford 7
Des Moines 5
Woodbridge 5
Messina 4
Wilmington 4
Brussels 3
Hangzhou 3
Helsinki 3
Jinan 3
Los Angeles 3
Pune 3
San Mateo 3
Zhengzhou 3
Lanzhou 2
Tianjin 2
Augusta 1
Guangzhou 1
Jiaxing 1
Kunming 1
Leawood 1
London 1
Monmouth Junction 1
Nanjing 1
Olomouc 1
Philadelphia 1
Ratoath 1
Santa Clara 1
Shenyang 1
Taizhou 1
Warsaw 1
Totale 340
Nome #
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports. 82
Folate pathway implications in advanced Non Small Cell Lung Cancer (NSCLC): impact of thymidylate synthase (TS) promoter and methlylenetetrahydrofolate reductase (MTHFR) C677T and A1298C variants expression on patients’ outcome and correlation with p53 codon 72 mutations. 79
Second-line therapy in advanced non-small cell lung cancer: Cytotoxic agents or tyrosine kinase inhibitors? Our experience. 71
Predicting sensitivity of non small cell lung cancer to gefitinib and erlotinib: is there still a role for clinical factors ? 62
Epidermal growth factor receptor (EGFR) G719C mutation as new determinant of long term survival and response in patients with non small cell lung cancer treated with erlotinib: a case report. 55
New biomarkers to predict response to pemetrexed-based chemotherapy in non small cell lung cancer: from 5,10-methylenetetrahydrofolate reductase promises to miRNAs revolution. 51
Impact of circulating microRNAs mir-22, mir-24 and mir-34a on response to pemetrexed in patients with non small cell lung cancer 50
Uncommon breast metastatic site and eribulin responsiveness in a heavily pretreated patient 46
Totale 496
Categoria #
all - tutte 1.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.973


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202057 0 0 0 0 0 13 10 7 2 5 20 0
2020/202158 6 1 11 6 4 5 1 0 1 6 12 5
2021/202261 1 9 0 2 0 0 4 3 0 19 6 17
2022/2023184 11 22 6 12 15 25 3 13 72 0 4 1
2023/202442 1 11 4 4 3 14 3 0 0 0 1 1
2024/202535 0 2 5 11 4 13 0 0 0 0 0 0
Totale 496